Skip to content

KLHL14 Expression as Predicting Factor of Invasiveness in pitNET

Evaluation of KLHL14 Expression as a Prognostic Factor of PitNET Invasiveness

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06247709
Enrollment
12
Registered
2024-02-08
Start date
2023-03-12
Completion date
2023-12-17
Last updated
2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasiveness, Neoplasm

Brief summary

OBJECTIVE: The objective of this study is to evaluate the correlation between KLHL14 expression and its cytoplasm-nuclear localisation and pituitary adenomas biological behaviour with particular focus on its role in epithelial mesenchymal transition and invasion of para and suprasellar regions. This is a multicenter and multidisciplinary study, with the involvement of the Departments of Neurosurgery of the University of Naples Federico II and the Department of Biosciences of the University of Teramo.

Detailed description

The investigators would like to analyse the possible correlations between the expression, the cytoplasm-nuclear localisation and the activity of the protein KLHL14 and pituitary adenomas biological behaviour with particular focus on its role in epithelial mesenchymal transition and invasion of para and suprasellar regions. This study will be conducted on biological sample collected during surgery and primary cellular line derived from those samples. Patients refer to neurosurgery for the detection of pituitary adenomas with various presenting symptoms that can be correlated to hormone production or to mass effect produced by the lesion on the optic apparatus or on the oculomotor nerves after invasion of the cavernous sinus. All patients undergo an ophthalmological clinical examination to define the presence of visual alteration and endocrinological assessment to determine eventual hormone hypersecretion. Finally, radiological exams, as magnetic resonance of the sellar region, are performed on patients to evaluate the extension of the pathology, its relationship to the surrounding neurovascular structures and therefore guide neurosurgical resection which is typically performed via an endoscopic endonasal transsphenoidal approach. Except for prolactin secreting pituitary adenomas, for which medical therapy with dopaminergic agonists is a viable approach, surgery with adenoma resection represent the gold standard for treatment.

Interventions

OTHERImmunohistochemical expression in pitNET cells of KLHL14

Lab essay evaluating the expression of KLHL 14

Sponsors

University of Teramo
CollaboratorOTHER
Federico II University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years

Inclusion criteria

* Adult men or women (age 18-70) * Patients affected by nonfunctioning pituitary adenomas.

Exclusion criteria

* Prisoners * Pregnant women * Patient under 18 years * Patients without capacity of discernment.

Design outcomes

Primary

MeasureTime frameDescription
Invasiveness degreeInvasiveness degree will be determined at the time of surgeryThe expression of KLHL14 in invasive pituitary adenomas

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026